ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
抗疫概念
908.714
-13.957
-1.51%
手動刷新
漲家數:
4
跌家數:
12
平家數:
2
市盈率:
- -
高:
927.380
開:
922.866
低:
906.728
收:
922.671
資料載入中...
總覽
新聞資訊
平安好醫生05月08日主力淨流出105.6萬元 散戶資金買入
市场透视
·
05-08
四環醫藥05月08日遭主力拋售183.4萬元
市场透视
·
05-08
中國中藥(00570)出現大手賣出110萬股,成交價$2.08,涉資228.8萬
阿斯达克财经
·
05-08
中證香港300中游指數報1032.38點,前十大權重包含比亞迪電子等
金融界
·
05-08
關稅動盪日,名私募們的倉位都在近年來的高點……
格隆汇
·
05-08
76億併購夢碎、15個月努力歸零,負增長下的新諾威危機四伏
钛媒体
·
05-08
中國生物製藥(01177)出現大手賣出150萬股,成交價$3.85,涉資577.5萬
阿斯达克财经
·
05-08
北京免疫方舟醫藥科技有限公司藥品申請臨牀試驗默示許可獲受理
金融界
·
05-08
同源康醫藥-B盤中異動 快速跳水5.02%
市场透视
·
05-08
羅氏宣佈投資超20億人民幣 在滬新建生物製藥生產基地
美港电讯
·
05-08
歌禮制藥-B:股價漲 3.32% 減肥藥催化
和讯网
·
05-08
快遞總裁收入曝光:李傑、劉強東、王衞,誰是快遞行業的超級霸總
蓝鲸财经
·
05-08
歌禮制藥-B股價上漲超3% 將公佈肥胖症藥物早期研究結果
DoNews
·
05-08
港股異動 | 歌禮制藥-B(01672)漲超3% 將公佈肥胖症候選藥物ASC47早期研究結果
智通财经
·
05-08
比亞迪(01211.HK)及青山控股退出智利鋰生產投資
阿斯达克财经
·
05-08
開拓藥業扳回一局
动脉网
·
05-08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":908.7142,"timestamp":1747123711734,"preClose":922.6707,"halted":0,"volume":315370946,"delay":0,"changeRate":-0.015126,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-13.956543,"latestTime":"05-13 16:00:00","open":922.8655,"high":927.38025,"low":906.72766,"amount":3207017304,"amplitude":0.022383,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747186200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747099800000,1747108800000],[1747112400000,1747123200000]],"pbRate":1.595396,"peRate":21.330383,"turnoverRate":0.004069,"increases":4,"decrements":13,"flats":1,"marketCap":625646477440,"floatMarketCap":515989849088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":927.38025,"amplitude":0.022383,"preClose":922.6707,"low":906.72766,"pbRate":"1.595396","latestPrice":908.7142,"volume":315370946,"delay":0,"open":922.8655,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":906.773,"twentyDayClose":771.593,"sixtyDayClose":858.56,"secType":"PLATE","market":"HK","turnoverRate":0.004069,"peRate":21.330383,"marketCap":625646477440,"floatMarketCap":515989849088,"timestamp":1747123711734,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":4,"down":12,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533903369","title":"平安好醫生05月08日主力淨流出105.6萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2533903369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533903369?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 16:15","pubTimestamp":1746692152,"startTime":"0","endTime":"0","summary":"05月08日, 平安好医生股价跌1.73%,报收7.40元,成交金额2840.4万元,换手率0.18%,振幅2.12%,量比0.54。平安好医生今日主力资金净流出105.6万元,上一交易日主力净流入142.1万元。该股近5个交易日下跌1.47%,主力资金累计净流出241.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1533.0万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508174300a476802b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508174300a476802b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","BK1515","BK1571","BK1615","BK1142","BK1617","BK1247","01833"],"gpt_icon":0},{"id":"2533906702","title":"四環醫藥05月08日遭主力拋售183.4萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533906702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533906702?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 16:15","pubTimestamp":1746692135,"startTime":"0","endTime":"0","summary":"05月08日, 四环医药股价跌1.39%,报收0.71元,成交金额1549.0万元,换手率0.23%,振幅4.17%,量比0.49。四环医药今日主力资金净流出183.4万元,上一交易日主力净流出47.5万元。该股近5个交易日下跌2.74%,主力资金累计净流入459.2万元;近20日主力资金累计净流入4152.0万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173545a6d7724b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173545a6d7724b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","00460","BK1600","BK1515"],"gpt_icon":0},{"id":"2533973012","title":"中國中藥(00570)出現大手賣出110萬股,成交價$2.08,涉資228.8萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2533973012","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533973012?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 16:08","pubTimestamp":1746691680,"startTime":"0","endTime":"0","summary":"[大手成交]中国中药(00570)在下午04:08出现大手卖出,成交量为110万,成交价为港币$2.08,涉资228.8万。至目前为止,股价无升跌,今日最高价为$2.1,而最低价为$2.06,总成交量为1.425千万股,总成交金额港币$2.966千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2505089317/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","00570","BK1191","BK1606"],"gpt_icon":0},{"id":"2533759509","title":"中證香港300中游指數報1032.38點,前十大權重包含比亞迪電子等","url":"https://stock-news.laohu8.com/highlight/detail?id=2533759509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533759509?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 15:52","pubTimestamp":1746690767,"startTime":"0","endTime":"0","summary":"数据统计显示,中证香港300中游指数近一个月上涨17.40%,近三个月下跌6.65%,年至今上涨5.11%。从中证香港300中游指数持仓的市场板块来看,香港证券交易所占比100.00%。从中证香港300中游指数持仓样本的行业来看,信息技术占比47.49%、工业占比36.94%、原材料占比8.89%、可选消费占比5.02%、通信服务占比1.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050816234694f03ab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050816234694f03ab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00285","BK1607","BK1580","BK1504","BK1149","LU0274383008.USD","LU0348766576.USD","BK1589","BK1540","BK1582","LU0348767384.USD","BK1515"],"gpt_icon":0},{"id":"2533692720","title":"關稅動盪日,名私募們的倉位都在近年來的高點……","url":"https://stock-news.laohu8.com/highlight/detail?id=2533692720","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533692720?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 15:39","pubTimestamp":1746689948,"startTime":"0","endTime":"0","summary":"医药生物、房地产等配置升温","market":"sg","thumbnail":"https://img3.gelonghui.com/c3726-9149b6ef-1eca-431e-9cc2-8de733fec32b.png?guru_height=616&guru_width=940","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/c3726-9149b6ef-1eca-431e-9cc2-8de733fec32b.png?guru_height=616&guru_width=940"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2147435","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2533217509","title":"76億併購夢碎、15個月努力歸零,負增長下的新諾威危機四伏","url":"https://stock-news.laohu8.com/highlight/detail?id=2533217509","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533217509?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 14:49","pubTimestamp":1746686954,"startTime":"0","endTime":"0","summary":"另外,新诺威还表示,目前,公司各项业务经营情况正常,本次交易的终止对公司现有生产经营活动不会造成重大不利影响。一场不被看好的重大整合在收购石药百克的两个关键信息披露节点,新诺威均出现大跌。而在2022年至2024年上半年,石药百克分别实现净利润6.21亿元、7.85亿元、3.9亿元与低承诺对应的是新诺威给出的高估值。公司陷入负增长,创新药业务要担责在2024年及2025年一季度,新诺威均出现营收、利润双降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050815011494f02809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050815011494f02809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0140636845.USD","BK1515","IE00B543WZ88.USD","IE0008369823.USD","LU1226287875.USD","IE00B031HY20.USD","LU1226287792.SGD","BK1191","IE00BZ08YT58.USD","LU1152091168.USD","LU1993786604.SGD","IE0008368742.USD","LU1226288253.USD","LU0880133367.SGD","LU1960683339.HKD","LU0067412154.USD","LU0501845795.SGD","LU1226288170.HKD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1807302812.USD","SG9999004220.SGD","LU0072913022.USD","LU1226287529.USD","IE00BZ08YS42.EUR","BK1521","01093","LU1152091754.HKD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2533354921","title":"中國生物製藥(01177)出現大手賣出150萬股,成交價$3.85,涉資577.5萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2533354921","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533354921?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 14:42","pubTimestamp":1746686520,"startTime":"0","endTime":"0","summary":"[大手成交]中国生物制药(01177)在下午02:42出现大手卖出,成交量为150万,成交价为港币$3.85,涉资577.5万。至目前为止,股价升0.522%,今日最高价为$3.89,而最低价为$3.81,总成交量为4.263千万股,总成交金额港币$1.637亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505087671/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1521","BK1191","BK1589","BK1515","01177"],"gpt_icon":0},{"id":"2533239389","title":"北京免疫方舟醫藥科技有限公司藥品申請臨牀試驗默示許可獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2533239389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533239389?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 14:06","pubTimestamp":1746684381,"startTime":"0","endTime":"0","summary":"5月8日,据CDE官网消息,北京免疫方舟医药科技有限公司联合申请药品“IMB071703注射液”,获得临床试验默示许可,受理号CXSL2500189。北京免疫方舟医药科技有限公司,成立于2017年,位于北京市,是一家以从事科技推广和应用服务业为主的企业。通过天眼查大数据分析,北京免疫方舟医药科技有限公司参与招投标项目4次,知识产权方面有商标信息5条,专利信息19条,此外企业还拥有行政许可6个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/08140650218876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1576","159938","BK1161","BK1583","03347","09939","BK1141","BK1574"],"gpt_icon":0},{"id":"2533923557","title":"同源康醫藥-B盤中異動 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533923557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533923557?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 13:51","pubTimestamp":1746683501,"startTime":"0","endTime":"0","summary":"2025年05月08日下午盘13时51分,同源康医药-B股票出现波动,股价大幅下挫5.02%。同源康医药-B股票所在的生物技术行业中,整体涨幅为0.03%。消息层面,截至13时51分,《同源康医药-B:2024年亏损3.87亿元》资讯为影响同源康医药-B的重要信息。该信息摘要如下:中证智能财讯同源康医药-B4月29日披露2024年度报告。以4月29日收盘价计算,同源康医药-B目前市净率约19.8倍,市销率约86815.03倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081351419752ce7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081351419752ce7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2533694063","title":"羅氏宣佈投資超20億人民幣 在滬新建生物製藥生產基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2533694063","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533694063?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 13:44","pubTimestamp":1746683049,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0273","BK0020","BK0059","BK0190","BK0099","BK1161","BK0184","BK0053","BK0012","BK1191","BK1574","09939","BK0188","BK0183","01477","600895","BK0075","159938","BK0028","BK1515","BK0011"],"gpt_icon":0},{"id":"2533929301","title":"歌禮制藥-B:股價漲 3.32% 減肥藥催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2533929301","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533929301?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 12:42","pubTimestamp":1746679365,"startTime":"0","endTime":"0","summary":"歌礼制药近日称将在西班牙马拉加举行的第 32 届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物 ASC47 的早期研究。此外,有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。5 月 7 日,世卫组织正式回应,治疗成年肥胖患者的指南正按程序全面制定,预计 2025 年 8 月或 9 月出台最终方案。中信证券此前指,预计后续相关事件将对减肥药板块形成反复催化,有望形成跨年度的主题行情。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081441239752da30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081441239752da30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","01477","BK1191","BK1161","BK1515"],"gpt_icon":0},{"id":"2533494912","title":"快遞總裁收入曝光:李傑、劉強東、王衞,誰是快遞行業的超級霸總","url":"https://stock-news.laohu8.com/highlight/detail?id=2533494912","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533494912?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 12:17","pubTimestamp":1746677836,"startTime":"0","endTime":"0","summary":"近年,总裁短剧爆火,剧中总裁们动辄年入数亿、挥金如土的剧情令无数人艳羡。但现实中,那些掌管着庞大企业的总裁们,真实年薪究竟咋样呢?尤其与大众生活息息相关的快递行业,其掌舵者的年收入究竟是多少呢?随着2024年快递公司年报陆续披露,答案逐渐揭晓。翻阅2024年快递公司年报,极兔、京东、中通等头部企业掌舵者的薪酬数字堪称“碾压级”的存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/256746","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0431992006.USD","LU0456827905.SGD","89618","LU0417516902.SGD","BK4579","BK1575","LU0456846285.SGD","IE0032431581.USD","LU0348825331.USD","SG9999002463.SGD","LU0320764599.SGD","LU1282651048.USD","LU0348805143.USD","LU1720050803.USD","BK1515","LU0588545490.SGD","BK4524","LU0359201612.USD","LU1481107354.HKD","LU0791591158.USD","BK4504","LU1282651121.HKD","LU0708995583.HKD","LU0051755006.USD","LU0456842615.SGD","06618","LU0259732245.USD","LU0244354667.USD","LU0326950275.SGD","BK4614","BK1610","BK4558","LU0469268626.HKD","LU1282649810.SGD","LU0149721374.USD","JD","86618","09618","BK1589","IE0008368742.USD","BK4503","IE00BGV7N243.SGD","LU0345775950.USD","LU0499858602.USD","LU1770036033.HKD","LU1328277881.USD","BK1591","BK1615","LU0039217434.USD","BK1583"],"gpt_icon":1},{"id":"2533294914","title":"歌禮制藥-B股價上漲超3% 將公佈肥胖症藥物早期研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294914","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533294914?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 12:06","pubTimestamp":1746677162,"startTime":"0","endTime":"0","summary":"5月8日,歌礼制药-B(01672)午前股价上涨3.32%,报6.54港元。公司将在西班牙马拉加举行的第32届欧洲肥胖症大会上报告肥胖症候选药物ASC47的早期研究结果。ASC47为歌礼自主研发的小分子激动剂,已获FDA批准与司美格鲁肽联用治疗肥胖症。此外,世卫组织计划制定成年肥胖患者治疗指南,预计2025年8月或9月出台。业内人士分析,减肥药板块有望形成跨年度主题行情。免责声明:本文内容由开放的智能模型自动生成,仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050812081994f00378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050812081994f00378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","01477","BK1161","BK1191","01672"],"gpt_icon":0},{"id":"2533943501","title":"港股異動 | 歌禮制藥-B(01672)漲超3% 將公佈肥胖症候選藥物ASC47早期研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533943501","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533943501?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 11:30","pubTimestamp":1746675049,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,歌礼制药-B涨超3%,截至发稿,涨3.48%,报6.55港元,成交额743.52万港元。消息面上,歌礼制药近日宣布将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。此外,有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","01672","BK1574","01477","BK1161"],"gpt_icon":0},{"id":"2533000948","title":"比亞迪(01211.HK)及青山控股退出智利鋰生產投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2533000948","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533000948?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 11:13","pubTimestamp":1746673980,"startTime":"0","endTime":"0","summary":"智利政府经济开发机构Corfo表示,中国电动车生产商比亚迪(01211.HK) 及金属集团青山控股退出在当地兴建锂阴极工厂的计划,有关项目受锂价下滑打击。《路透》报道,青山控股退出投资2.33亿美元生产12万公吨磷酸铁锂的计划。智利国家资源部亦披露比亚迪已于1月提交有意退出计划的通知。比亚迪去年押后在当地的2.9亿美元厂房项目,项目预计每年生产5万吨磷酸铁锂用于阴极。智利为全球第二大锂生产国,拟发展更多本土锂加工产业。锂是电动车电池的关键金属。(fc/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-07 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230710124610420_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230710124610420_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1438540/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1580142542.USD","SG9999006514.SGD","LU0175139822.USD","LU0516422952.EUR","BK1594","LU0084288322.USD","LU2399975544.HKD","LU0819123356.HKD","LU0516423174.USD","LU1064131003.USD","LU1969619763.USD","LU0359201612.USD","LU1997244956.HKD","LU2778985437.USD","002594","LU0823414478.USD","LU0229945570.USD","LU2580892862.HKD","LU0143863784.USD","LU0348735423.USD","00285","LU0540923850.HKD","LU2495084118.USD","LU1961090484.USD","LU1880383440.USD","BK0155","LU0511384066.AUD","LU1861219969.SGD","LU0165289439.USD","BYDDY","SG9999015945.SGD","LU0269904917.USD","HYDD.SI","BK0183","LU0417516738.SGD","BK1515","EVS.SI","LU0823426480.USD","LU0289961442.SGD","BK1509","LU0326950275.SGD","LU2249611893.SGD","LU1064130708.USD","01211","81211","LU1781817850.SGD","LU2663582299.SGD","SG9999015978.USD","BK1149","LU0307460666.USD"],"gpt_icon":0},{"id":"2533342917","title":"開拓藥業扳回一局","url":"https://stock-news.laohu8.com/highlight/detail?id=2533342917","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533342917?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 10:38","pubTimestamp":1746671880,"startTime":"0","endTime":"0","summary":"开拓药业核心产品KX-826(福瑞他恩)与米诺地尔联合治疗男性脱发效果显著,优于米诺地尔单药,引发市场关注。KX-826是雄激素受体拮抗剂,曾历经挫折,现以化妆品形式上市并贡献营收,联用研究再显成效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050810401694efec9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050810401694efec9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":8,"totalSize":314,"code":"91000000","status":"200"}]}}